John C Clohisy Selected Research

Femoracetabular Impingement

1/2022	Rate of continued conservative management versus progression to surgery at minimum 1-year follow-up in patients with pre-arthritic hip pain.
11/2020	Rate of Surgery and Baseline Characteristics Associated With Surgery Progression in Young Athletes With Prearthritic Hip Disorders.
11/2020	Short-term Clinical Outcomes of Hip Arthroscopy Versus Physical Therapy in Patients With Femoroacetabular Impingement: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
1/2020	Rapidly Progressive Arthritis in Femoroacetabular Impingement: Patient Characteristics and Risk Factors for Total Hip Arthroplasty by the Age of Forty.
7/2019	Complications associated with combined surgical hip dislocation and periacetabular osteotomy for complex hip deformities.
4/2017	Do Radiographic Parameters of Dysplasia Improve to Normal Ranges After Bernese Periacetabular Osteotomy?
8/2013	Molecular characterization of articular cartilage from young adults with femoroacetabular impingement.
8/2013	Why do hip arthroscopy procedures fail?
11/2012	Periacetabular osteotomy and combined femoral head-neck junction osteochondroplasty: a minimum two-year follow-up cohort study.
7/2012	Clinical outcomes analysis of conservative and surgical treatment of patients with clinical indications of prearthritic, intra-articular hip disorders.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John C Clohisy Research Topics

Disease

33	Pain (Aches) 01/2022 - 02/2005
22	Congenital Abnormalities (Deformity) 11/2022 - 01/2004
17	Osteoarthritis 01/2021 - 02/2005
15	Osteolysis 01/2021 - 03/2002
12	Femoracetabular Impingement 01/2022 - 01/2005
9	Hip Dislocation 07/2019 - 02/2010
6	Arthritis (Polyarthritis) 01/2020 - 11/2003
6	Developmental Dysplasia of the Hip 05/2019 - 09/2010
5	Venous Thromboembolism 01/2021 - 06/2006
5	Infections 09/2016 - 12/2004
4	Wounds and Injuries (Trauma) 01/2021 - 04/2007
4	Surgical Wound Infection 07/2019 - 02/2015
4	Venous Thrombosis (Deep-Vein Thrombosis) 09/2016 - 06/2006
4	Osteonecrosis (Kienbock's Disease) 12/2014 - 07/2010
3	Legg-Calve-Perthes Disease (Perthes Disease) 01/2021 - 04/2017
3	Heterotopic Ossification (Ectopic Ossification) 07/2019 - 06/2011
3	Pulmonary Embolism 09/2016 - 08/2014
2	Disease Progression 01/2022 - 05/2011
2	Hemorrhage 01/2021 - 09/2012
2	Inflammation (Inflammations) 01/2020 - 01/2020
2	Thromboembolism 01/2016 - 12/2015
2	Hip Osteoarthritis (Coxarthrosis) 05/2015 - 05/2012
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 08/2013 - 08/2012
2	Femoral Neck Fractures 01/2012 - 07/2010
1	Salter-Harris Fractures 01/2022
1	Atrial Fibrillation 01/2021
1	Drug Hypersensitivity (Drug Allergy) 01/2021
1	Nausea 01/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Wound Infection (Wound Infections) 07/2019
1	Neoplasms (Cancer) 12/2018
1	Multiple Hereditary Exostoses (Hereditary Multiple Exostoses) 04/2017
1	Stress Fractures (Stress Fracture) 09/2016
1	Hypesthesia (Numbness) 09/2016
1	Obesity 09/2015
1	Paralysis (Palsy) 12/2014
1	Vascular System Injuries 12/2014
1	Cartilage Diseases (Cartilage Disease) 08/2013
1	Down Syndrome (Down's Syndrome) 04/2013
1	Tendinopathy (Tendonitis) 02/2010

Drug/Important Bio-Agent (IBA)

5	Polyethylene (Polythene)IBA 01/2021 - 12/2010
5	CytokinesIBA 08/2013 - 03/2002
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 06/2011
4	Warfarin (Coumadin)FDA LinkGeneric 01/2016 - 06/2006
3	Collagen Type II (Type II Collagen)IBA 01/2020 - 08/2013
3	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 08/2013
3	3,5-tetrahydroaldosterone sulfate (THAS)IBA 02/2015 - 08/2012
2	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2021 - 01/2020
2	ThrombospondinsIBA 01/2020 - 01/2020
2	aggrecanaseIBA 01/2020 - 01/2020
2	Aggrecans (Aggrecan)IBA 01/2020 - 01/2020
2	DisintegrinsIBA 01/2020 - 01/2020
2	Metalloproteases (Metalloproteinases)IBA 01/2020 - 01/2020
2	Matrix Metalloproteinase 13IBA 01/2020 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2019 - 09/2007
2	Polymethyl Methacrylate (Sol)IBA 07/2006 - 03/2002
2	NF-kappa B (NF-kB)IBA 11/2003 - 03/2002
1	ElementsIBA 11/2022
1	ORALIT (ORS)IBA 01/2022
1	Alcian BlueIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Narcotics (Narcotic Analgesics)IBA 01/2021
1	apixabanIBA 01/2021
1	Biological ProductsIBA 01/2021
1	1- phenyl- 3- azabicyclo(3.1.0)hexane- 2,4- dioneIBA 11/2020
1	InterleukinsIBA 01/2020
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Dihydrotachysterol (AT 10)IBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 05/2015
1	Messenger RNA (mRNA)IBA 08/2013
1	Interleukin-8 (Interleukin 8)IBA 08/2013
1	ChemokinesIBA 08/2013
1	tyramine-deoxysorbitolIBA 07/2012
1	Lysergic Acid Diethylamide (LSD)IBA 05/2012

Therapy/Procedure

37	Osteotomy 01/2022 - 01/2004
21	Hip Replacement Arthroplasty (Total Hip Replacement) 10/2021 - 06/2006
15	Arthroplasty 01/2021 - 07/2010
7	Replacement Arthroplasty 01/2021 - 01/2007
6	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2021 - 09/2007
5	Activities of Daily Living (ADL) 01/2020 - 01/2014
3	Conservative Treatment 01/2022 - 09/2009
3	Therapeutics 01/2022 - 01/2007
3	Reoperation 11/2020 - 08/2013
3	Operative Surgical Procedures 08/2012 - 01/2007
3	Bone Transplantation (Bone Grafting) 02/2011 - 01/2009
2	Decompression 12/2014 - 01/2005
1	Spinal Anesthesia 01/2021
1	Contraindications 01/2021
1	Physical Therapy Modalities (Physical Therapy Technique) 11/2020
1	Debridement 07/2019
1	Punctures 09/2016
1	Anesthesia 02/2015
1	Length of Stay 02/2015
1	General Anesthesia 02/2015
1	Conduction Anesthesia (Regional Anesthesia) 02/2015
1	Hip Prosthesis 06/2014
1	Aftercare (After-Treatment) 07/2013
1	Homologous Transplantation 01/2011